The phosphatase DUSP2 constrains lymphoid remodeling and immunotherapy response in lung squamous carcinoma.

Wang J, Zhang X, Wu Y, Zong R, Guo M, Yi L, Zhang L, Wang C, Gao X, Shi L, Pan Y, Li W, Liu L, Zhao Y, Liu Z, Lu D

Open source

DOI
10.1016/j.ymthe.2026.03.022
Published
2026 Jul 1
Container
Molecular therapy : the journal of the American Society of Gene Therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ymthe.2026.03.022,
  title = {The phosphatase DUSP2 constrains lymphoid remodeling and immunotherapy response in lung squamous carcinoma.},
  author = {Wang J and Zhang X and Wu Y and Zong R and Guo M and Yi L and Zhang L and Wang C and Gao X and Shi L and Pan Y and Li W and Liu L and Zhao Y and Liu Z and Lu D},
  year = {2026},
  journal = {Molecular therapy : the journal of the American Society of Gene Therapy},
  doi = {10.1016/j.ymthe.2026.03.022},
  url = {https://doi.org/10.1016/j.ymthe.2026.03.022}
}

RIS

TY  - JOUR
TI  - The phosphatase DUSP2 constrains lymphoid remodeling and immunotherapy response in lung squamous carcinoma.
AU  - Wang J
AU  - Zhang X
AU  - Wu Y
AU  - Zong R
AU  - Guo M
AU  - Yi L
AU  - Zhang L
AU  - Wang C
AU  - Gao X
AU  - Shi L
AU  - Pan Y
AU  - Li W
AU  - Liu L
AU  - Zhao Y
AU  - Liu Z
AU  - Lu D
PY  - 2026
JO  - Molecular therapy : the journal of the American Society of Gene Therapy
DO  - 10.1016/j.ymthe.2026.03.022
UR  - https://doi.org/10.1016/j.ymthe.2026.03.022
ER  - 

APA

J, W., X, Z., Y, W., R, Z., M, G., L, Y., L, Z., C, W., X, G., L, S., Y, P., W, L., L, L., Y, Z., Z, L., & D, L. (2026). The phosphatase DUSP2 constrains lymphoid remodeling and immunotherapy response in lung squamous carcinoma.. Molecular therapy : the journal of the American Society of Gene Therapy. https://doi.org/10.1016/j.ymthe.2026.03.022

Source records